Skincare Science: The Role of Nicotinamide in Acne Treatments

Acne vulgaris is one of the most common dermatological conditions globally, affecting millions of adolescents and adults. For decades, the standard treatment relied on benzoyl peroxide, retinoids, or oral antibiotics. While effective, these therapies often cause skin irritation, redness, dryness, and contribute to antibiotic resistance.

In recent years, Nicotinamide (Vitamin B3) has emerged as a cornerstone of modern topical skincare formulations. Unlike antibiotics, Nicotinamide does not induce bacterial resistance. Instead, it works by targeting the root causes of acne: sebum production and skin inflammation. Nicotinamide suppresses sebaceous gland activity, reduces skin redness, and accelerates epidermal barrier repair by boosting ceramide synthesis.

When combined with a proven topical antibiotic like Clindamycin, the result is a highly synergistic formulation. Nicotinamide offsets the dryness caused by standard acne treatments while amplifying the clearing effect. Medgraaft's Twacha Cosmoderma division specializes in this aesthetic science, manufacturing dermatological creams and gel formulations that deliver visible clinical results without compromising the skin barrier.